INTRODUCTION
iLiNS‐DYAD, nausea, vomiting, fever
SECONDARY
Common morbidity symptoms such as fever, poor appetite, nausea and vomiting are experienced by many pregnant and lactating women (Regodón Wallin et al., Low nutrient status during pregnancy and lactation could contribute to the occurrence and severity of morbidity symptoms (Papathakis et al., Small‐quantity (20 g/day) lipid‐based nutrient supplements (SQ‐LNSs) were developed for pregnant and lactating women by collaborators of the International Lipid‐based Nutrient Supplements (iLiNS) Project (Arimond et al., We previously reported pregnancy outcomes from the iLiNS‐DYAD trials in Ghana (Adu‐Afarwuah et al., The aim of this secondary outcome analysis was to compare morbidity symptoms among women enrolled in the iLiNS‐DYAD trials in Ghana and Malawi. We hypothesised that within country, the three treatment groups would differ in the prevalence and mean percentage of days of monitoring when women had morbidity symptoms during pregnancy and lactation.